Observational Study of Drug Naive Diabetes Receiving Insulin Therapy

NCT03710811 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-10-18

No results posted yet for this study

Summary

A multi-centre, open-label trial to investigate the efficacy and possible mechanism of Continuous Subcutaneous Insulin Infusion treatment in patients with drug naive type 2 diabetes.

Conditions

Interventions

DRUG

Insulin

Continuous Subcutaneous Insulin Infusion

Sponsors & Collaborators

  • Zhejiang Provincial People's Hospital

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2020-08-30
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710811 on ClinicalTrials.gov